Santé Ventures
Austin · Invests in Austin, Texas · Website
Check size
🔒 $•• – $••Thesis
Healthcare and life science venture firm founded in 2006, managing over $1B across five funds and 60+ portfolio companies, investing in breakthrough biotech, medtech and healthtech and typically leading or co-leading entry rounds with a board seat. Explicit inbound path: a 'Submit a Business Plan' page with published investment criteria and a stated 2-3 week response.
Profile drafted from public signals. Our research team reviews every firm.
Partners & team
14 contacts on file
Santé Ventures in the news
Singapore Economic Development Board (EDB)
Life sciences investment giant to give Singapore MedTech startups international boost
2 days ago
The Straits Times
New platform for healthcare startup growth
2 months ago
BioPharma Dive
A biotech VC sees early signs of a turnaround for startups
6 months ago
bioxconomy.com
Santé Ventures closes $330m Fund V for biotechs
7 months ago
The Business Journals
AI startup Graici raises $7.5M to automate Medicaid renewals with data wallet
7 months ago
Pulse 2.0
Santé Ventures Closes Record $330 Million Fund V To Back Early-Stage Biotech, Medtech, And Digital Health
7 months ago
The Business Journals
Santé Ventures closes $330M fund to back early-stage health tech startups
7 months ago
Fierce Biotech
Early-stage investor Santé Ventures gins up $330M to spread across biotech, medtech and digital health
7 months ago
MobiHealthNews
Santé Ventures raises $330 million for Fund V
7 months ago
citybiz
Santé Ventures Raises $330 Million for Fifth Fund
7 months ago
PR Newswire
Brado and Santé Ventures Partner to Transform Patient Navigation and Engagement
8 months ago
MobiHealthNews
Axon Therapies secures $32M and more digital health funding
11 months ago
BioSpace
Axon Therapies Raises $32M in Oversubscribed Series A to Transform Heart Failure Treatment
11 months ago
Axios
Santé Ventures closing in on $300M fund
Jun 2025
Fierce Healthcare
This venture capitalist sees plenty of promise in AI in healthcare. But challenges are ahead, too
Jun 2023
MedCity News
Santé Ventures’ Kevin Lalande on how to drive returns in an era of overvaluation
Jun 2019
Add Santé Ventures to your investor list
Sign up free to save investors, see partner contacts, and track your raise.
Sign up